🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
0.9500
-0.0199 (-2.05%)
At close: Nov 20, 2026, 4:00 PM EST
1.040
+0.090 (9.47%)
After-hours: Nov 20, 2026, 4:36 PM EST

Cocrystal Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-8.83-17.5-17.98-38.84-14.19
Depreciation & Amortization
0.070.130.190.190.38
Asset Writedown & Restructuring Costs
---19.09-
Stock-Based Compensation
0.270.640.80.860.72
Other Operating Activities
00.11-0.01-0.02-0.24
Change in Accounts Receivable
----0.56
Change in Accounts Payable
-0.25-0.92.05-0.320.22
Change in Other Net Operating Assets
0.041.360.47-1.68-0.17
Operating Cash Flow
-8.19-16.49-14.67-21.44-12.72
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.01-0.01-0.12-0.07-0.05
Investing Cash Flow
-0.01-0.01-0.12-0.07-0.05

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
---0.01-0.03-0.04
Net Debt Issued (Repaid)
---0.01-0.03-0.04
Issuance of Common Stock
5.37-4-38.51
Financing Cash Flow
5.37-3.99-0.0338.47

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-2.84-16.49-10.79-21.5425.7

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-8.2-16.49-14.78-21.51-12.77
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-0.73-1.62-1.53-2.64-1.73
Levered Free Cash Flow
-4.95-10.29-10.01-13.12-7.28
Unlevered Free Cash Flow
-4.95-10.29-10.01-13.12-7.28

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
0.290.142.34-2.710.6
SEC Filings: 10-K · 10-Q